These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33872414)

  • 21. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study.
    Mansour NI; El-Sayed SM; El-Gohary NS; Abdel-Aziz NI; El-Subbagh HI; Ghaly MA
    Bioorg Chem; 2022 Oct; 127():105966. PubMed ID: 35728294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
    Jarapula R; Badavath VN; Rekulapally S; Manda S
    Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, anticancer, and docking of some S- and/or N-heterocyclic derivatives as VEGFR-2 inhibitors.
    El-Adl K; Abdel-Rahman AA; Omar AM; Alswah M; Saleh NM
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100237. PubMed ID: 34862655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
    Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
    Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, In vitro, and Docking Analysis of C-3 Substituted Coumarin Analogues as Anticancer Agents.
    Thakur A; Kaur K; Sharma P; Singla R; Singh S; Jaitak V
    Curr Comput Aided Drug Des; 2021; 17(2):161-172. PubMed ID: 31987025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
    Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
    Ahmed MF; Belal A
    Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study.
    El-Sayed MA; El-Husseiny WM; Abdel-Aziz NI; El-Azab AS; Abuelizz HA; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):199-209. PubMed ID: 29251017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Biological Activity Evaluation of Coumarin-3-Carboxamide Derivatives.
    Phutdhawong W; Chuenchid A; Taechowisan T; Sirirak J; Phutdhawong WS
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
    El-Helby AA; Sakr H; Eissa IH; Al-Karmalawy AA; El-Adl K
    Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900178. PubMed ID: 31596514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and molecular docking studies of novel pomalidomide-based PROTACs as potential anti-cancer agents targeting EGFR
    O Aboelez M; Belal A; Xiang G; Ma X
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1196-1211. PubMed ID: 35470756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity.
    Ahmed NM; Youns MM; Soltan MK; Said AM
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microwave-assisted synthesis, spectroscopic characterization, and biological evaluation of fused thieno[2,3-d]pyrimidines as potential anti-cancer agents targeting EGFR
    Aboelez MO; Kamel MS; Belal A; El Badry Abdel-Aziz A; Abourehab MAS; Abdel-Ghany H; A El Hamd M; El-Remaily MAEAA
    Mol Divers; 2023 Apr; 27(2):901-917. PubMed ID: 35780205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antiproliferative evaluation of novel 3,5,8-trisubstituted coumarins against breast cancer.
    Salem MG; Alqahtani AM; Mali SN; Alshwyeh HA; Jawarkar RD; Altamimi AS; Alshawwa SZ; Al-Olayan E; Saied EM; Youssef MF
    Future Med Chem; 2024; 16(11):1053-1073. PubMed ID: 38708686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives.
    Xiao Z; Lei F; Chen X; Wang X; Cao L; Ye K; Zhu W; Xu S
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700407. PubMed ID: 29732607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 1,3,4-oxadiazoles linked with the 1,2,3-triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase.
    Mahmoud MA; Mohammed AF; Salem OIA; Gomaa HAM; Youssif BGM
    Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200009. PubMed ID: 35195309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study.
    Takla FN; Bayoumi WA; El-Messery SM; Nasr MNA
    Sci Rep; 2023 Aug; 13(1):13370. PubMed ID: 37591917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.